Hallmarks of cancer stem cell metabolism

P Sancho, D Barneda, C Heeschen - British journal of cancer, 2016 - nature.com
Cancer cells adapt cellular metabolism to cope with their high proliferation rate. Instead of
primarily using oxidative phosphorylation (OXPHOS), cancer cells use less efficient …

Niclosamide: Beyond an antihelminthic drug

W Chen, RA Mook Jr, RT Premont, J Wang - Cellular signalling, 2018 - Elsevier
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of
people worldwide. However recent studies have indicated that niclosamide may have broad …

Cancer stem cells and chemoresistance: The smartest survives the raid

J Zhao - Pharmacology & therapeutics, 2016 - Elsevier
Chemoresistant metastatic relapse of minimal residual disease plays a significant role for
poor prognosis of cancer. Growing evidence supports a critical role of cancer stem cell …

Cancer stem cells (CSCs): metabolic strategies for their identification and eradication

EM De Francesco, F Sotgia, MP Lisanti - Biochemical Journal, 2018 - portlandpress.com
Phenotypic and functional heterogeneity is one of the most relevant features of cancer cells
within different tumor types and is responsible for treatment failure. Cancer stem cells …

The Wnt/β-catenin pathway in ovarian cancer: a review

RC Arend, AI Londoño-Joshi, JM Straughn Jr… - Gynecologic …, 2013 - Elsevier
Objective Ovarian cancer is the deadliest gynecologic malignancy and the fifth leading
cause of death from cancer in women in the US Since overall survival remains poor, there is …

Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug

Y Li, PK Li, MJ Roberts, RC Arend, RS Samant… - Cancer letters, 2014 - Elsevier
The rapid development of new anticancer drugs that are safe and effective is a common goal
shared by basic scientists, clinicians and patients. The current review discusses one such …

Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance

M Teeuwssen, R Fodde - Journal of clinical medicine, 2019 - mdpi.com
Ovarian cancers represent the deadliest among gynecologic malignancies and are
characterized by a hierarchical structure with cancer stem cells (CSCs) endowed with self …

Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer

C Liu, W Lou, Y Zhu, N Nadiminty, CT Schwartz… - Clinical cancer …, 2014 - AACR
Purpose: Enzalutamide, a second-generation antiandrogen, was recently approved for the
treatment of castration-resistant prostate cancer (CRPC) in patients who no longer respond …

Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28

PN Le, JD McDermott, A Jimeno - Pharmacology & therapeutics, 2015 - Elsevier
The Wnt signaling pathways are a group of signal transduction pathways that play an
important role in cell fate specification, cell proliferation and cell migration. Aberrant …